title: [Diagnosis and therapy of autoimmune thrombocytopenia. Recommendations of a joint Expert Group of DGHO, DGTI, DTH].
authors.affiliation: Klinik f. Hämatologie/Onkologie, Caritasklinik St. Theresia, Saarbrücken, Deutschland. a.matzdorff@caritasklinik.de
authors.forename: Axel
authors.initials: A
authors.lastname: Matzdorff
authors.forename: Aristoteles
authors.initials: A
authors.lastname: Giagounidis
authors.forename: Andreas
authors.initials: A
authors.lastname: Greinacher
authors.forename: Erhard
authors.initials: E
authors.lastname: Hiller
authors.forename: Volker
authors.initials: V
authors.lastname: Kiefel
authors.forename: Hannes
authors.initials: H
authors.lastname: Müller-Beissenhirtz
authors.forename: Helmut
authors.initials: H
authors.lastname: Ostermann
authors.forename: Mathias
authors.initials: M
authors.lastname: Rummel
authors.forename: Ulrich J
authors.initials: UJ
authors.lastname: Sachs
authors.forename: Abdulgabar
authors.initials: A
authors.lastname: Salama
mesh_terms: D000305:Adrenal Cortex Hormones / Q000627:therapeutic use*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies / Q000097:blood; D001565:Benzoates / Q000009:adverse effects / Q000627:therapeutic use; D001780:Blood Coagulation Tests; D001792:Blood Platelets / Q000276:immunology; D001803:Blood Transfusion; D002648:Child; D003430:Cross-Sectional Studies; D003937:Diagnosis, Differential; D019317:Evidence-Based Medicine; D005858:Germany; D006470:Hemorrhage / Q000145:classification / Q000209:etiology; D006760:Hospitalization; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects / Q000627:therapeutic use; D007116:Immunization, Passive; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D010976:Platelet Count; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000097:blood / Q000175:diagnosis* / Q000188:drug therapy* / Q000209:etiology; D011720:Pyrazoles / Q000009:adverse effects / Q000627:therapeutic use; D011961:Receptors, Fc / Q000627:therapeutic use; D053628:Receptors, Thrombopoietin / Q000819:agonists*; D011993:Recombinant Fusion Proteins / Q000009:adverse effects / Q000627:therapeutic use; D012008:Recurrence; D000069283:Rituximab; D013156:Splenectomy; D013926:Thrombopoietin / Q000009:adverse effects / Q000627:therapeutic use
chemical_list: D000305:Adrenal Cortex Hormones; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D001565:Benzoates; D006834:Hydrazines; D007166:Immunosuppressive Agents; D011720:Pyrazoles; D011961:Receptors, Fc; D053628:Receptors, Thrombopoietin; D011993:Recombinant Fusion Proteins; C082218:MPL protein, human; D000069283:Rituximab; D013926:Thrombopoietin; C488777:romiplostim; C520809:eltrombopag